These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12210803)

  • 21. Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta).
    Gandy S; DeMattos RB; Lemere CA; Heppner FL; Leverone J; Aguzzi A; Ershler WB; Dai J; Fraser P; St George Hyslop P; Holtzman DM; Walker LC; Keller ET
    Mech Ageing Dev; 2004 Feb; 125(2):149-51. PubMed ID: 15037022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-mediated immunotherapy for Alzheimer's disease.
    Solomon B
    Curr Opin Investig Drugs; 2007 Jul; 8(7):519-24. PubMed ID: 17659471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies.
    Lanz TA; Schachter JB
    J Neurosci Methods; 2008 Mar; 169(1):16-22. PubMed ID: 18160105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.
    Kuo YM; Emmerling MR; Lampert HC; Hempelman SR; Kokjohn TA; Woods AS; Cotter RJ; Roher AE
    Biochem Biophys Res Commun; 1999 Apr; 257(3):787-91. PubMed ID: 10208861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
    Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
    Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease.
    Siemers ER; Friedrich S; Dean RA; Gonzales CR; Farlow MR; Paul SM; Demattos RB
    Clin Neuropharmacol; 2010; 33(2):67-73. PubMed ID: 20375655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
    Arbel M; Solomon B
    Trends Immunol; 2007 Dec; 28(12):511-3. PubMed ID: 17981084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
    Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
    Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophoretic separation of amyloid beta peptides in plasma.
    Lewczuk P; Esselmann H; Bibl M; Paul S; Svitek J; Miertschischk J; Meyrer R; Smirnov A; Maler JM; Klein C; Otto M; Bleich S; Sperling W; Kornhuber J; Rüther E; Wiltfang J
    Electrophoresis; 2004 Oct; 25(20):3336-43. PubMed ID: 15490456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
    Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
    Fagan AM; Mintun MA; Mach RH; Lee SY; Dence CS; Shah AR; LaRossa GN; Spinner ML; Klunk WE; Mathis CA; DeKosky ST; Morris JC; Holtzman DM
    Ann Neurol; 2006 Mar; 59(3):512-9. PubMed ID: 16372280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma biomarkers of Alzheimer's disease.
    Kawarabayashi T; Shoji M
    Curr Opin Psychiatry; 2008 May; 21(3):260-7. PubMed ID: 18382225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine.
    Li SB; Wang HQ; Lin X; Xu J; Xie Y; Yuan QF; Yao ZB
    Chin Med J (Engl); 2005 Apr; 118(8):660-4. PubMed ID: 15899121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monoclonal antibodies against amyloid-beta from healthy adults.
    Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M
    Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
    Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.